# A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults

> **NCT00239577** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 86 (actual)

## Conditions studied

- Dengue

## Interventions

- **BIOLOGICAL:** Live attenuated tetravalent dengue vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00239577
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04-05
- **Primary completion:** 2007-06-19
- **Final completion:** 2007-06-19
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2019-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00239577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00239577, "A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00239577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*